v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
11 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Revenue $ 8,196 $ 13,102
Cost of revenue 1,623 2,873
Total gross profit 6,573 10,229
Operating expenses:    
Research and development 26,928 59,952
Sales and marketing 2,475 6,348
General and administrative 11,299 47,632
Goodwill impairment 0 5,377
Total operating expenses 40,702 119,309
Loss from operations (34,129) (109,080)
Other income (expense), net:    
Interest expense (2,465) (5,286)
Interest income 10 2,433
Change in fair value of derivative warrant liabilities (1,664) 22,132
Change in fair value of earn-out liability 0 19,207
Transaction costs 0 (927)
Other income 7 0
Total other income (expense), net (4,112) 37,559
Net loss before provision for income taxes (38,241) (71,521)
Provision for income taxes 0 0
Net loss $ (38,241) $ (71,521)
Weighted average shares used in computing net loss per share attributable to common stockholders – basic [1] 23,337,127 102,300,852
Weighted average shares used in computing net loss per share attributable to common stockholders – diluted [1] 23,337,127 102,300,852
Net loss per share attributable to common stockholders—basic $ (1.64) $ (0.7)
Net loss per share attributable to common stockholders—diluted $ (1.64) $ (0.7)
[1] Weighted-average shares have been retroactively restated to give effect to the Business Combination.